Webinar

Meet Challenges In Expressing Next-Gen Immunotherapies And Other Advanced Biologics

Source: Lonza

Biological pipelines are evolving from standard antibody formats to next-generation biologics. These advances increase pressure on cell line construction timelines and create challenges in identifying cell lines that meet production needs. As a result, highly optimized cell technologies are required to address these demands. In this webinar, we use internal data and a customer case study to demonstrate how the GS System® and GS piggyBac® technology can rise to the challenge of producing novel IgG-engineered cancer immunotherapies.

access the Webinar!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Lonza